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Abstract
Background: Metastatic bone disease is a common and severe complication in patients with advanced cancer.
Radiotherapy (RT) has long been established as an effective local treatment for metastatic bone disorder. This study
assesses the effects of RT combined with muscle-training exercises in patients with unstable bone metastases of the
spinal column from solid tumors. The primary goal of this study is to evaluate the feasibility of muscle-training exercises
concomitant to RT. Secondly, quality of life, fatigue, overall and bone survival, and local control will be assessed.
Methods/Design: This study is a single-center, prospective, randomized, controlled, explorative intervention study with
a parallel-group design to determine multidimensional effects of a course of exercises concomitant to RT on patients
who have unstable metastases of the vertebral column, first under therapeutic instruction and subsequently performed
by the patients themselves independently for strengthening the paravertebral muscles. On the days of radiation
treatment the patients will be given four different types of exercises to ensure even isometric muscle training of
all the spinal muscles. In the control group progressive muscle relaxation will be carried out parallel to RT. The
patients will be randomized into two groups: differentiated muscle training or progressive muscle relaxation with
30 patients in each group.
Discussion: Despite the clinical experience that RT is an effective treatment for bone metastases, there is
insufficient evidence for a positive effect of the combination with muscle-training exercises in patients with
unstable bone metastases. Our previous DISPO-1 trial showed that adding muscle-training exercises to RT is
feasible, whereas this was not proven in patients with an unstable spinal column. Although associated with
several methodological and practical challenges, this randomized controlled trial is needed.
Trial registration: ClinicalTrials.gov, identifier: NCT02847754. Registered on 27 July 2016.
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Background
Bone is the third most common organ affected by me-
tastases, after the lung and liver [1]. Bone metastases of
the spinal column are a common manifestation of dis-
tant relapse from many types of solid cancers, especially
those arising in the lung, breast and prostate [2]. For
hematological malignancies, bone involvement can also
be extensive in patients with multiple myeloma, and
bone may be a primary or secondary site of disease in-
volvement in patients with lymphoma [1–4]. Thirty
percent of all skeletal metastases and 10% of all primary
bone tumors are located in the spinal column [5].
Spinal bone metastases are located in the lumbar (52%),
thoracic (36%) and cervical (12%) regions [6]. The exact
mechanism behind the occurrence of bone metastasis
is not fully understood. It is postulated that bone me-
tastases arise as a detachment of tumor cells from the
primary tumor and are mainly dragged by intravascular
penetration into the bone. In the bones, the tumor cells
cause an imbalance in bone remodeling which leads to
local changes of the bone structure presenting as osteo-
lytic or mixed osteolytic/osteoblastic phenotype. Many
metastatic bone lesions cause few or no symptoms but
regarding skeletal-related events, pain is the most com-
mon symptom, and many patients with bone metastasis
experience significant pain at some point in their
disease course [7]. Other skeletal-related events can in-
clude limitations in daily activities, fatigue, pathological
fractures, hypercalcemia and neurological deficits.
Pathological fractures occur in 5% and spinal cord com-
pression is found in 10–15% of patients [5]. As a part
of the central axis, the spinal column is important for
patients’ mobility. Impaired stability may lead to a
devastating long-term impact on functioning, mobility,
independence, health and quality of life (QoL).
We have already shown in our previous study
(DISPO-1 trial) that in those patients with stable bone
metastases of the spine concomitant radiotherapy (RT)
and differentiated sports therapy are safe and feasible
and have an advantageous effect on QoL [8–12]. This
trial was designed to evaluate a differentiated strength
training of the paravertebral muscles in cancer patients
with unstable spinal bone metastasis under concomitant
RT. Strengthening of the paravertebral musculature does
not only have positive effects on the perception of pain,
but may also improve QoL and fatigue. The implemen-
tation of isometric muscle training increases the blood
flow in the affected vertebral segment. This circum-
stance may, in combination with RT, result in a better
response to therapy. In patients with stable metastases
there is consistent evidence that the risk of fracture in
connection with an injury of the spinal cord involving
neurological deficits is not increased [9]. Many patients
develop significant anxiety from complications such as
fracture, exacerbation of pain or neurological impair-
ment. This fear of a serious event may create an unin-
tended “vicious circle” consisting of immobility, pain and
ever-decreasing physical performance. In almost all
cases, pain, anxiety and impaired physical mobility are
associated with a reduction in QoL and often lead to so-
cial negative effects. In our DISPO-1 study we showed
that in combination with RT a targeted, regular and dif-
ferentiated training of the paravertebral musculature in
stable bone metastases is well tolerated by the majority
of patients [9–12]. So far, however, no specific workout
therapeutic measures in unstable bone metastases of the
spine during and after RT have been described. The ex-
tent to which specific, regular and differentiated training
of the spinal muscles can be performed may be dimin-
ished by the reduced general condition, the pain situ-
ation and the fear of fractures in affected patients.
Therefore, the feasibility of this study is the greatest
challenge. In a large retrospective study, we were able to
show that abandoning general corset use in patients with
spinal metastases does not significantly cause increased
rates of pathological fractures [8]. The study is designed
to integrate physical training with its multidimensional
effects in patients with unstable bone metastases of the
vertebrae who are undergoing RT. Therefore, the pri-
mary objective of this study is to evaluate the feasibility
of an isometric training of the paravertebral musculature
concomitant with palliative RT for unstable spinal bone
metastases. Further study objectives are survival, treat-
ment response to irradiation and clinical parameters
such as pain, QoL and fatigue.
Methods/Design
This is a single-centre, prospective, randomized, con-
trolled, exploratory intervention study with a parallel-
group design to determine the multidimensional effects
of first, a guided, and thereafter, independently contin-
ued, targeted development training of the paravertebral
muscles in patients with unstable spinal metastases con-
comitant to RT. Since the bone metastases of different
patients may be located at different levels of the verte-
bral column, four different types of exercises are selected
to ensure even isometric muscle training of the entire
spinal musculature. To achieve exercises with high ef-
fectiveness, high quality and at the same time ensure
high levels of safety, the study was designed and will be
carried out by physical therapists, sports scientists as
well as sports physicians and radiation oncologists in an
interdisciplinary setting. In the control group a progres-
sive muscle relaxation will be carried out parallel to RT.
The plan foresees the recruitment, over a period of 12
months, of a total of 60 patients with unstable metastasis
of the vertebral column who are scheduled to undergo
RT. Prior to their enrollment into the study, the patients
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will receive a staging of the vertebral column in connec-
tion with their radiation treatment-planning computed
tomography (CT) to measure bone density. The detec-
tion of unstable bone metastases is essential for accurate
staging and optimal treatment. After the baseline results
have been recorded, the patients will be randomized
into one of the two groups: differentiated muscle train-
ing (n = 30) or progressive muscle relaxation (n = 30).
The interventions will start at the same time as RT,
taking place on each day of irradiation (Mondays to
Fridays inclusive) for a period of 2 weeks. Each sport
intervention as well as the progressive muscle relax-
ation will last approximately 15 min a day over the 2-
week period. After completion of RT the training group
will continue the exercise under the instruction of the
therapist and later on their own independently at home.
Patients will record the exercises and the pain load in a
daily protocol report. Participants in the control group
will do no further measurements at home. The target
parameters will be measured and recorded at the end
of the irradiation period (t1) and 12 weeks (t2) and 6
months following the end of the irradiation period (t3).
Follow-up measurements are scheduled to take place
12, 18 and 24 months after the end of irradiation.
Recruitment and randomization
Patients will be given information on the study by the
medical personnel of the radiotherapy department in
connection with the planning of the RT regimen. This
will take place approximately 1–2 weeks prior to the
start of RT. Importantly, the mentioned time range does
not differ to the time range concerning regular patients
treated outside the study.
A block randomization procedure will be used to en-
sure the even distribution of the patients into the two
groups. The patients will then be assigned 1:1 into one
of the two treatment arms by the study director (or an
authorized representative) on the basis of the baseline
measurements. The randomization procedure will be
carried out by a central office. The study personnel re-
sponsible for the recruitment and baseline measure-
ments will have no access to the randomization list, and
the study director no influence on patient recruitment.
The recruitment phase will be concluded with the at-
tainment of the planned number of patients (60 patients
in total). It will last for 12 months, and is scheduled to
start in June 2017. Regular study participation will end 2
years after enrollment into the study or, where applic-
able, with the respective patient’s death.
Inclusion criteria
 Patients with a histologically secured tumor
diagnosis, with a secondarily diagnosed
solitary/multiple metastatic processes in the thoracic
or lumbar spine or in the os sacrum
 Indication for RT of the osseous metastatic
processes
 Age: between 18 and 80 years
 Karnofsky Index ≥70 [13]
 Signed Declaration of Informed Consent
 Bisphosphonate therapy or anti-RANK ligand
antibody therapy
Exclusion criteria
 Significant neurological or psychiatric disorders,
including dementia and epileptic seizures
 Other severe disorders that in the judgement of the
study director may prevent the patient’s
participation in the study
 Lacking or diminished legal capacity
 Any medical of psychological condition that the
study director considers a preventive factor for the
patient’s ability to complete the study or to
adequately understand the scope of the study and to
give their consent
 Unable to perform the exercises
 Indication for operation to the unstable spinal bone
metastasis
Intervention group
Sport concept: differentiated isometric exercise of the
autochthonous muscles
Exercises in the “all-fours” position:
Starting position: arms and upper legs perpendicular
to the floor, hands and knees positioned vertically under
the shoulders and hips, respectively. The spine is as far
as possible in the zero position over all segments. The
elbows are slightly flexed. From the starting position, the
right arm is anteverted at the shoulder from the sagittal
level in the ventrocranial direction, at the very most
until it is horizontal. The arm is then dropped again
until it reaches the starting position, but it does not
touch the ground again until the series of exercises is
ended. The patient should keep their spine completely
stable while the arm is being moved. The exercise is
then repeated with the left arm. Duration: two series per
arm, repeating each series of exercises ten times.
Exercises in the “swimming” position:
Starting position: prone, the toes are on the floor, the
arms are stretched forward. The shoulder girdle and
the arms are lifted from the ground and the view is di-
rected toward the bottom. The exercise is executed by
the arms, which move diametrically opposed in small,
rapid movements up and down. The trunk is strained.
Breathing should be continued during the exercise. If
possible, the legs can be simultaneously lifted from the
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ground. Duration: two series each 30 s, with a 60-s
break in between.
Exercises in the “forearm support” position:
Starting position: the body weight rests on the tiptoes
and the forearms, elbows are placed directly under the
shoulders. The body is tense, just raising the back, the
buttocks are at a maximum of shoulder height and the
face is directed to the ground. The position is to be held
for 15 s and breathing continued here. Duration: two
series, with a 60-s break in between.
Exercises with elastic “rubber” band:
Starting position: upright standing position, feet shoul-
der width apart. The knee joints are slightly bent and
the buttocks and the torso tense. The elastic band is
held with both arms at the level of the umbilicus.
Duration: the elastic band is stretched until a slight
tremor of the arms occurs, the trunk remains tense,
while continuing breathing smoothly. The arms are
moved slowly on the chest and back to the level of the
umbilicus. During the entire range of motion power
should be maintained. Duration: three series with 15-s
duration intervals between series: 60–90 s.
Control group
Physical measure: muscle relaxation
Study participants in the control arm will receive a pro-
gressive muscle relaxation instead of isometric muscle
training. This will occur for about 2 weeks, parallel to
the radiation treatment, carried out under guidance of
an audio file. The sessions will last about 15 min. After
completion of RT no further meetings are planned.
Questionnaire diagnostics
The secondary endpoints, such as fatigue, quality of life,
and anxiety, will be recorded using validated question-
naires (EORTC QLQ C30 FA13 [14], EORTC QLQ C30
BM22 [15] and the questionnaire to record stress in can-
cer patients (FBK) according to Herschbach [16] (t0, t2,
t3, Fig. 1). Furthermore, all patients will also be asked to
record their pain history using a Pain Diary (documenta-
tion of medication daily during treatment, once weekly
after the end of treatment, Visual Analogue Scale (VAS)
pain scale). Figure 2 shows the Standard Protocol Items:
Recommendations for Interventional Trials (SPIRIT)
figure that guides our trial stages.
Assessment of the primary and secondary endpoints
The aim of the study is to evaluate the feasibility of the
defined training program. The feasibility as the primary
endpoint was defined as the completion of the training
program (mentioned above) up to 3 months after the
end of RT (t2; Fig. 1) Additional file 1. Progression-free
and fracture-free survival, improved response to RT by
means of bone density, and clinical parameters, such as
pain, quality of life, and fatigue, constitute secondary
study objectives. In this study each fracture will be eval-
uated. Bone fracture rate will be calculated at baseline
and after 3 and 6 months after RT by imaging, as well as
if new clinical symptoms appear (Fig. 1).
Fig. 1 Flow chart of DISPO-2 trial; t0 = randomization, t1 = end of RT, t2 (3 months) = restaging, t3 (6 months) = restaging. RT radiotherapy
Fig. 2 Standard Protocol Items: Recommendations for Interventional
Trials (SPIRIT) figure
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Progression-free and fracture-free survival, improved
response to RT by means of bone density, and clinical
parameters, such as pain, quality of life, and fatigue, con-
stitute secondary study objectives. In addition, the
changes between baseline and week 12 and week 24
(end of intervention) regarding pain symptoms between
the intervention arm (muscle exercises) and the control
arm (progressive muscle relaxation) will be compared.
The feasibility will be expressed in percent in tabular
form and will cover the complete performance of the ex-
ercise program up to the t2 interval. As described above,
the patients enrolled into the study will be subjected to
a CT screening of the vertebral column with bone densi-
tometry as per the standards of the follow-up investigation
(t2). The study analyses provide for several follow-up
meetings after the end of irradiation. Re-calcification
should be the main outcome by means of increased bone
density. Furthermore the psycho-oncological parameters
on t1, t2 and t3 will be documented and evaluated.
Following the RT period the patients will independently
keep a Pain Diary and a record of their training exer-
cises. No further radiological examinations will be con-
ducted in the course of this study (Fig. 1).
Radiotherapy
Treatment is simulated with a CT by using a 3-mm slice
thickness taken within the involved vertebral region. On
the basis of the planning CT, risk organs and clinical tar-
get volume (CTV) are contoured. The spinal cord is
contoured on the basis of a visible target on the CT scan
with the help of fusion with magnetic resonance imaging
(MRI). CTV confirms planning target volume (PTV).
The gross tumor volume (GTV) includes the macro-
scopic tumor. The PTV includes at least the metastasis-
affected vertebra. PTV is equal to CTV. The total dose
is also determined and varies between individual patients
in individual irradiation formats. Consequently, there are
also different single doses and fractions. Percutaneous
RT occurs within 2–4 weeks using 6-MV individually
formed beams (Linac, multileaf collimator) after CT
scan-based 3D or intensity-modulated radiotherapy
(IMRT) planning [17].
Therapy dropout criteria
 At the patient’s wish
 Medical condition requiring the discontinuation of
therapy in the opinion of the study director or
patient
 Insufficient compliance
In case of early dropout from the study the planned
follow-up scheme will be continued. For non-evaluable
patients the reason in the Case Report Forms (CRF) is
recorded. The evaluable patients have the opportunity to
revoke individual investigations (for example, MRI) and
still continue as a study patient.
Statistical analysis
The total number of patients undergoing RT in the radi-
ation oncology department of the Heidelberg University
Clinic for metastatic processes in the vertebral column
in the recruitment period is approximately 120, about 90
of whom will fulfill the inclusion criteria. The relatively
weakly distinct compliance of this group of patients not-
withstanding, it should be possible to achieve the
planned recruitment target within a period of 6 months.
Stratification factors were dispensed due to the expect-
ation of collective patient homogeneity. On account of
the explorative character of this study it is not pos-
sible to estimate the total number of cases; with a
scheduled number of 30 patients per group, it will,
however, be possible to detect a standardized mean-value
effect [18] of 0.8 with a power of 80% and an α signifi-
cance level of 5%.
Discussion
Osseous metastases of the vertebral column are the
main localization of bone metastases and are associated
with a poor prognosis. Unstable bone-affecting meta-
static processes in vertebral bodies constitute a frequent
secondary disorder in connection with a variety of pri-
mary tumors. Palliative percutaneous RT is one of the
options available on this occasion. On the one hand,
symptoms, such as painful impairments of mobility, pain
at rest, a fear of pathological fractures, and fatigue, result
in a pronounced diminution in the patients’ quality of
life, while on the other hand the therapy of such dis-
orders involves protracted, cost- and time-intensive
measures. Pathological fracture in patients with bone
metastases is an acute risk with the danger of the
emergence of symptoms of paraplegia. Because the
development of such a fracture is so devastating to a
cancer patient, increased emphasis is now being
placed on prevention. To assess whether RT indeed
improves unstable bone quality and bone strength in
addition to differentiated sport therapy, we initiated
this study. In line with our previous study (DISPO-1)
the effect of RT on bone density showed that bone
density increased after RT. However, there is insuffi-
cient evidence to conclude whether or not RT leads
to improved bone quality and increased bone strength
in patients suffering from unstable solid bone metas-
tases. The aim of this explorative study is to evaluate
the feasibility of muscle-training exercises and to
evaluate the progression-free and fracture-free survival
time and the improvement of unstable bone density,
as well as to assess other clinical parameters, such as
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pain, quality of life, and fatigue, as secondary endpoints. A
further objective of the study is to make a contribution to
the integration of a regimen of physical training exercises
with its multidimensional effects into future therapeutic
concepts for patients with unstable osseous metastases of
the vertebral bodies. No stratification factors will be used
in this study. Additional complexity associated with the
stratification procedure adds only little additional profit,
and we believe that the randomization will provide bal-
anced groups anyway. To the best of our knowledge, ours
is the first study to compare the effects of physical training
exercises in patients with an unstable spinal column. The
long-term consequences of such interventions are cur-
rently unknown, and further research is necessary to ex-
pand on these findings.
Trial status
Not completed patient recruitment.
Additional file
Additional file 1: SPIRIT 2013 Checklist: recommended items to address
in a clinical trial protocol and related documents. (DOC 121 kb)
Abbreviations
CRF: Case Report Form; CT: Computed tomography; CTV: Clinical target
volume; GCP: Good Clinical Practice; GTV: Gross tumor volume; PTV: Planning
target volume
Acknowledgements
We thank our German Bone Cancer Research Group Members for their great
effort.
Funding
Not applicable
Availability of data and materials
The data used in this analysis is from publications available in the public
domain.
Authors’ contributions
SEW and HR developed and planned this trial. TB is responsible for statistical
considerations/basis of the analysis. RF, TBo, IS, EM, TS, NHN, HR and JD
estimated the treatment of bone metastases. JW, FS and HR performed the
physical exercise. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
If they are interested in participating in the study, the potential study
candidates will be given the Patient Information Sheet including the
Declaration of Informed Consent, with the request that they re-read the
information carefully and, if they consent to the conditions, return the
signed declaration when they attend the next appointment. Patients will
also be given the opportunity to ask the study staff further questions.
The study protocol, Patient Information Sheet and the Declaration of
Informed Consent will be submitted to the Heidelberg University Ethics
Committee responsible for the study directors for review. The study will
commence only after receipt of the approval of the Ethics Committee.
The Heidelberg Ethics Committee approved this study on 23 May 2016
(S-223/2016).
The study directors will immediately notify the Ethics Committee of all changes
made in the study protocol that may have an impact on the safety of the
patients. Furthermore, the Ethics Committee will also be notified of all severe
adverse events reported to the study directors and of the regular or premature
termination of the study. The procedures described in the submitted study
protocol regarding the performance, evaluation and documentation of this
study has been selected in such a way that the principles of the Good Clinical
Practice (GCP) guidelines are observed. The regulations regarding medical
confidentiality and data protection are fulfilled.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Radiation Oncology, University Hospital Heidelberg, Im
Neuenheimer Feld 400, 69120 Heidelberg, Germany. 2Department of Medical
Biometry, University Hospital Heidelberg, Im Neuenheimer Feld 305, 69120
Heidelberg, Germany. 3National Center for Radiation Oncology (NCRO),
Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld
400, 69120 Heidelberg, Germany. 4Department of Medical Oncology,
National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University
Hospital, Heidelberg, Germany. 5Department of Preventive Oncology,
National Center for Tumor Diseases (NCT) Heidelberg, German Cancer
Research Center (DKFZ), Heidelberg, Germany.
Received: 28 July 2016 Accepted: 15 March 2017
References
1. Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma; analysis of 1000
autopsied cases. Cancer Band 3. 1950;1:74–85.
2. Berretoni B, Carter J. Mechanism of cancer metastasis to bone. J Bone Joint
Surg. 1986;68A:308–12.
3. Bubendorf L, et al. Metastatic patterns of prostate cancer: an autopsy study
of 1,589 patients. Hum Pathol Band 31. 2000;5:578–83.
4. Cheville AL, et al. Therapeutic exercise during outpatient radiation therapy
for advanced cancer. Am J Phys Med Rehabil. 2010;89:611–9.
5. Harrington KD. Impending pathologic fractures from metastatic malignancy:
evaluation and management. Instr Course Lect. 1986;35:357-81.
6. Pilge H, et al. Diagnostics and therapy of spine metastases. Orthopade.
2011;40:185–94.
7. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P,
Isaacs WB, Semenza GL, Simons JW. Overexpression of hypoxia-inducible factor
1alpha in common human cancers and their metastases. Cancer Res Band 59.
1999;22:5830–5.
8. Rief H, et al. The influence of orthopedic corsets on the incidence of
pathological fractures in patients with spinal bone metastases after
radiotherapy. BMC Cancer. 2015;15:745.
9. Rief H, et al. The effect of resistance training during radiotherapy on spinal
bone metastases in cancer patients—a randomized trial. Radiother Oncol.
2014;112(1):133–9.
10. Rief H, et al. Quality of life and fatigue of patients with spinal bone
metastases under combined treatment with resistance training and
radiation therapy—a randomized pilot trial. Radiat Oncol. 2014;9:151.
11. Rief H, et al. Pain response of resistance training of the paravertebral
musculature under radiotherapy in patients with spinal bone metastases—a
randomized trial. BMC Cancer. 2014;5;14:485.
12. Rief H, et al. Feasibility of isometric spinal muscle training in patients with
bone metastases under radiation therapy—first results of a randomized
pilot trial. BMC Cancer. 2014;14:67.
13. Verger E, Conill C, Karnofsky C. Can Karnofsky performance status be
transformed to the Eastern Cooperative Oncology Group Scoring Scale and
vice versa. Eur J Cancer. 1992;28:1328–30.
14. Aaronson NK, et al. The European Organization for Research and Treatment
of Cancer QLQ-C30: a quality-of-life instrument for use in international
clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.
15. Chow E, Nguyen J, Zhang L, Tseng LM, Hou MF, Fairchild A, Vassiliou V, et
al. International field testing of the reliability and validity of the EORTC QLQ-
Welte et al. Trials  (2017) 18:155 Page 6 of 7
BM22 module to assess health-related quality of life in patients with bone
metastases. Cancer. 2012;118(5):1457–65.
16. Herschbach P, Keller M, Knight L, Brandl T, Huber B, Henrich G, Marten-
Mittag B. Psychological problems of cancer patients: a cancer distress
screening with a cancer-specific questionnaire. Br J Cancer. 2004;91:504–11.
17. Ryu S, Pugh SL, Gerszten PC, Yin FF, Timmerman RD, Hitchcock YJ, et al.
RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for
localized (1–3) spine metastases: phase 2 results. Pract Radiat Oncol. 2014;4:
76–81.
18. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed.
Hillsdale: Lawrence Erlbaum Associates; 1988.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Welte et al. Trials  (2017) 18:155 Page 7 of 7
